23ANDME, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2006-04-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.23andme.com
Clinical Trials
6
Active:1
Completed:4
Trial Phases
2 Phases
Phase 1:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Not Applicable
1 (33.3%)Study of 23ME-01473 in Patients With Advanced Solid Malignancies
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- 23andMe, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT06290388
- Locations
- 🇺🇸
START Midwest, Grand Rapids, Michigan, United States
🇺🇸Oregon Health & Science University, Portland, Oregon, United States
🇺🇸START Center for Cancer Care, San Antonio, Texas, United States
A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
Phase 1
Active, not recruiting
- Conditions
- Clear Cell Renal Cell CarcinomaEpithelial Ovarian CancerMSI-H CancerExtensive-stage Small-cell Lung CancerFallopian Tube CancerCancer With A High Tumor Mutational BurdenSolid TumorPrimary Peritoneal CarcinomaNeuroendocrine Tumors
- Interventions
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- 23andMe, Inc.
- Target Recruit Count
- 141
- Registration Number
- NCT05199272
- Locations
- 🇺🇸
Stanford Cancer Institute, Palo Alto, California, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸Karmanos Cancer Institute, Detroit, Michigan, United States
23andMe IPF Research Study
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- 23andMe, Inc.
- Target Recruit Count
- 690
- Registration Number
- NCT05028894
- Locations
- 🇺🇸
23andMe, Sunnyvale, California, United States
Web-based Weight Loss Intervention
Not Applicable
Completed
- Conditions
- Overweight and Obesity
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- 23andMe, Inc.
- Target Recruit Count
- 63656
- Registration Number
- NCT03400696
- Locations
- 🇺🇸
23andMe, Mountain View, California, United States
Web-based Genetic Research on Lupus
Completed
- Conditions
- Systemic Lupus Erythematosus
- First Posted Date
- 2015-08-21
- Last Posted Date
- 2018-01-10
- Lead Sponsor
- 23andMe, Inc.
- Target Recruit Count
- 5000
- Registration Number
- NCT02530944
- Locations
- 🇺🇸
Www.23Andme.Com/Lupus, Mountain View, California, United States
- Prev
- 1
- 2
- Next
News
No news found